Senzime acquires Respiratory Motion for up to $44M

Senzime AB has signed an agreement to acquire 100% of Respiratory Motion, Inc. for an initial consideration of USD 19 million plus potential earn-out of up to USD 25 million. The acquisition expands Senzime's patient monitoring portfolio.

“Through the acquisition, Senzime expands its product portfolio within the market for monitoring of vital signs and extends the Company’s capability to capture a larger share of the patient journey outside of the operating room.”senzime.com

• 1 source
• senzime.comSenzime has entered into an agreement to acquire the US company Respiratory Motion | SenzimeJun 1, 2022

Summarized from public sources; check the original articles before acting on it.